Jason Sanghwa Oh, MD | |
743 Spring St Ne, Gainesville, GA 30501-3715 | |
(770) 219-9000 | |
Not Available |
Full Name | Jason Sanghwa Oh |
---|---|
Gender | Male |
Speciality | Critical Care (intensivists) |
Experience | 17 Years |
Location | 743 Spring St Ne, Gainesville, Georgia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1063617413 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Wellstar Kennestone Hospital | Marietta, GA | Hospital |
Wellstar Cobb Hospital | Austell, GA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Wellstar Medical Group, Llc | 6709065402 | 1839 |
News Archive
The American Dental Association (ADA) today asked the U.S. Food and Drug Administration (FDA) to establish appropriate classifications for tooth-whitening chemicals.
Gamma Medica-Ideas, Inc. ("GMI"), a leading developer of digital molecular imaging systems, announced today that it has signed an exclusive license and commercialization agreement with Mayo Clinic to further develop and commercialize a suite of technologies invented by a team of Mayo physicians and scientists, headed by Michael O'Connor, PhD.
Argos Therapeutics today announced that its Arcelis immunotherapy targeted at diabetes demonstrated potential for preventing and treating the disease in non-obese diabetic (NOD) mice, according to a peer-reviewed article published in Molecular Therapy.
The American Cancer Society, the largest non-government, not-for-profit funding source of cancer research in the United States, has approved funding for three new research grants totaling over $1.7 million to investigators at Yale University.
› Verified 2 days ago
Entity Name | Georgia Emergency Department Services, P.c. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1508886912 PECOS PAC ID: 5597751032 Enrollment ID: O20040517001016 |
News Archive
The American Dental Association (ADA) today asked the U.S. Food and Drug Administration (FDA) to establish appropriate classifications for tooth-whitening chemicals.
Gamma Medica-Ideas, Inc. ("GMI"), a leading developer of digital molecular imaging systems, announced today that it has signed an exclusive license and commercialization agreement with Mayo Clinic to further develop and commercialize a suite of technologies invented by a team of Mayo physicians and scientists, headed by Michael O'Connor, PhD.
Argos Therapeutics today announced that its Arcelis immunotherapy targeted at diabetes demonstrated potential for preventing and treating the disease in non-obese diabetic (NOD) mice, according to a peer-reviewed article published in Molecular Therapy.
The American Cancer Society, the largest non-government, not-for-profit funding source of cancer research in the United States, has approved funding for three new research grants totaling over $1.7 million to investigators at Yale University.
› Verified 2 days ago
Entity Name | Wellstar Medical Group, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1558664003 PECOS PAC ID: 6709065402 Enrollment ID: O20110127000374 |
News Archive
The American Dental Association (ADA) today asked the U.S. Food and Drug Administration (FDA) to establish appropriate classifications for tooth-whitening chemicals.
Gamma Medica-Ideas, Inc. ("GMI"), a leading developer of digital molecular imaging systems, announced today that it has signed an exclusive license and commercialization agreement with Mayo Clinic to further develop and commercialize a suite of technologies invented by a team of Mayo physicians and scientists, headed by Michael O'Connor, PhD.
Argos Therapeutics today announced that its Arcelis immunotherapy targeted at diabetes demonstrated potential for preventing and treating the disease in non-obese diabetic (NOD) mice, according to a peer-reviewed article published in Molecular Therapy.
The American Cancer Society, the largest non-government, not-for-profit funding source of cancer research in the United States, has approved funding for three new research grants totaling over $1.7 million to investigators at Yale University.
› Verified 2 days ago
Entity Name | Cep America Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1124073721 PECOS PAC ID: 6608056171 Enrollment ID: O20121126000128 |
News Archive
The American Dental Association (ADA) today asked the U.S. Food and Drug Administration (FDA) to establish appropriate classifications for tooth-whitening chemicals.
Gamma Medica-Ideas, Inc. ("GMI"), a leading developer of digital molecular imaging systems, announced today that it has signed an exclusive license and commercialization agreement with Mayo Clinic to further develop and commercialize a suite of technologies invented by a team of Mayo physicians and scientists, headed by Michael O'Connor, PhD.
Argos Therapeutics today announced that its Arcelis immunotherapy targeted at diabetes demonstrated potential for preventing and treating the disease in non-obese diabetic (NOD) mice, according to a peer-reviewed article published in Molecular Therapy.
The American Cancer Society, the largest non-government, not-for-profit funding source of cancer research in the United States, has approved funding for three new research grants totaling over $1.7 million to investigators at Yale University.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Jason Sanghwa Oh, MD 400 Tower Rd Ne Ste 200, Marietta, GA 30060-9412 Ph: (770) 422-1372 | Jason Sanghwa Oh, MD 743 Spring St Ne, Gainesville, GA 30501-3715 Ph: (770) 219-9000 |
News Archive
The American Dental Association (ADA) today asked the U.S. Food and Drug Administration (FDA) to establish appropriate classifications for tooth-whitening chemicals.
Gamma Medica-Ideas, Inc. ("GMI"), a leading developer of digital molecular imaging systems, announced today that it has signed an exclusive license and commercialization agreement with Mayo Clinic to further develop and commercialize a suite of technologies invented by a team of Mayo physicians and scientists, headed by Michael O'Connor, PhD.
Argos Therapeutics today announced that its Arcelis immunotherapy targeted at diabetes demonstrated potential for preventing and treating the disease in non-obese diabetic (NOD) mice, according to a peer-reviewed article published in Molecular Therapy.
The American Cancer Society, the largest non-government, not-for-profit funding source of cancer research in the United States, has approved funding for three new research grants totaling over $1.7 million to investigators at Yale University.
› Verified 2 days ago
James D Jackson, M.D. Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 1285 Sims St, Gainesville, GA 30501 Phone: 770-219-8583 | |
Eileen Javellana, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 725 Jesse Jewell Pkwy Se, Gainesville, GA 30501 Phone: 678-207-4373 Fax: 770-533-4727 | |
Dr. Nitya S Chandra, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 S Enota Dr Ne Ste 100, Gainesville, GA 30501 Phone: 770-534-2020 Fax: 770-534-8025 | |
Dr. Lisa Armsrees Gillespie, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 743 Spring St Ne, Gainesville, GA 30501 Phone: 770-219-8420 | |
Dr. Noelle Claudine Stanley, MD Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 1211 Sherwood Park Dr Ne Ste B, Gainesville, GA 30501 Phone: 770-219-9179 | |
Kedric Naylor, Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 743 Spring St Ne, Gainesville, GA 30501 Phone: 770-219-9000 Fax: 770-538-7872 | |
Dr. William Nathan Blake, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 743 Spring St Ne, Ngpg Inpatient Medicine, Gainesville, GA 30501 Phone: 770-219-6000 Fax: 770-219-6021 |